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Controversies Regarding Cardiac Cellular Regeneration
Twopapers in this issue address thepotential of theheart to generatenewmyocytes.The first paper by Anversa and colleagues describes the evidence that myocytes
can divide and generate newmyocytes and focuses on evidence from experimental and
humanmodels where both bonemarrow and cardiac stems cells appear to differentiate
into myocytes. The second paper by Murry and colleagues notes that a wide range of
non-myogenic cell types can improve ventricular function when transplanted into
damaged hearts, suggesting that some of the benefit may result from paracrine stimu-
lation rather thanmyocardial regeneration.Bothpapers agree that the future for cardiac
regeneration with cellular based therapies appears promising, but many questions
remain to be answered before this therapy can be widely adopted. See pages 1769
and 1777.
Page 1807
Atherosclerosis
Pravastatin May Lead to Clearance of Oxidized Phospholipids
Oxidized phospholipids (OxPLs) are a major component of oxidized LDL whichcorrelates with cardiovascular risk. The effects of statins on OxPL are poorly
understood. In this study, approximately 200 children with familial hypercholesterol-
emia (FH) were randomized to either pravastatin or placebo. Children with FH had
lower ratios ofOxPL to apolipoprotein B-100 (apoB) and higher levels of apoB bound
to both immunoglobulin (Ig)G and IgM. Pravastatin raised the ratio ofOxPL to apoB
and levels of lipoprotein (a) [Lp(a)]. One possible explanation for these findings is that
Lp(a) is upregulated by statins and bindsOxPL as it is released fromperipheral sources.
This study suggests that children with FH have evidence of an immune response to
OxPL which may represent a novel mechanism of mobilization and clearance of
oxidized LDL. See page 1803. See figure.
Page 1815
Heart Rhythm Disorders
Benefit of ICD Begins at Least Six Months After Revascularization
Several implantable cardioverter-defibrillator (ICD) trials have demonstrated abenefit to ICD therapy in patients with ischemic cardiomyopathy, but there
appears tobenobenefit during the immediate post revascularizationperiodbecause the
risk of sudden cardiac death is low. In this paper, Goldenberg and colleagues analyzed
data from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
based on the time elapsed since the most recent revascularization and the benefit from
ICD implantation. They report that there was no benefit to ICD therapy for those
subjects who had undergone revascularization within the previous six months. The
benefit was only present in those who had not been recently revascularized. This study
suggests that it is reasonable to delay ICD implantation for at least six months after
revascularization. See page 1811. See figure.
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Microvolt T-Wave Alternans Predicts Risk of Arrhythmic Death
Microvolt T-wave alternans (MTWA) describes the phenomenon of subtle beatto beat variations in the amplitude of the T-wave thought to reflect altered
calcium handling in areas of damaged myocardium. It has been proposed as a risk
marker for sudden cardiac death (SCD), but most prior studies have been either
underpowered or did not properly adjusted for other clinical predictors of SCD.Chow
and colleagues report their results from almost 800 subjects with ischemic cardiomy-
opathy (ejection fraction 35%) followed for a mean of 18 months who underwent
MTWA testing. One-third of patients had a negative MTWA; the others were either
positive or indeterminate. Aftermultivariable adjustment, a non-negativeMTWA test
was associated with a two fold increase in the risk of all-causemortality and SCD. This
study demonstrates that MTWA adds significant, independent prognostic informa-
tion regarding the risk for SCD. See page 1820.
Page 1837
Heart Failure
Exercise Training Improves Neurohormonal Status and LV Function
While it has previously been shown that exercise training can improve symptomsin subjects with left ventricular dysfunction (LVD), the effects of exercise
training on neurohormonal markers have not been studied. Passino and colleagues
randomized patients with LVD to either an exercise program targeting a heart rate of
60% of the maximal oxygen uptake (VO2) or standard care. Patients in the exercise
group had a 14% improvement in workload and a 9% improvement in their ejection
fraction; B-type natriuretic peptide and norepinephrine levels both decreased by
approximately 30%while no such changeswere noted in the standard care group.This
study demonstrates that a targeted, progressive exercise program can improve symp-
toms, quality of life, ejection fraction, and can reverse the neurohormonal activation
that accompanies LVD. See page 1835. See figure.
Cardiac Imaging
Radiation Dose Three Times Higher for MSCT vs Angiography
Multislice computed tomography (MSCT) scanning is rapidly gaining accep-tance as an alternative to conventional X-ray coronary angiography but con-
cerns exist regarding the radiation dose that patients receive. Coles and colleagues
studied patients referred for angiography and compared coronaryMSCT scan prior to
their angiography in a real world, real patient fashion. The mean effective dose for
MSCTcoronary angiographywas14.7mSvwhile that fromconventional angiography
was 5.6mSv.This dose of radiation is predicted to cause 1 case of fatal cancer per 3,600
MSCT studies, compared to 1 per 1,400 for traditional angiography. The dose
received from a 16-slice scanner was found to be higher than a 12-slice scan, but the
authors comment that it is difficult to predict the dose exposure from a 64-slice scan.
While this radiation dose is not prohibitive, strategies that can reduce the radiation
exposure without limiting the quality of the study need to be identified. See page
1840.
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Preclinical Studies
Removing Contrast From the Coronary Sinus May Protect the Kidneys
Contrast-induced nephropathy (CIN) can have serious negative conse-quences for patients undergoing coronary angiography. Most of the
contrast injected into the coronary arteries during angiography is returned to
the systemic circulation via the coronary sinus. Michishita and Fujii postulated
that a suction catheter placed into the coronary sinus could remove the blood
containing contrast from the body. After passing through a filter of coated
charcoal beads designed to adsorb the iodine, the blood could then be returned
to the femoral vein. In a swine model, nearly 50% of the injected iodine was
retained in the filter, and thus was not toxic to the kidneys. This technique of
removing contrast containing blood from the coronary sinus may be a novel
technique for preventing CIN. See page 1866. See figure.
